Innovative Molecular Analysis Technologies for Cancer Research (R21)
The summary for the Innovative Molecular Analysis Technologies for Cancer Research (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Molecular Analysis Technologies for Cancer Research (R21): This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research focused on the inception and early-stage development of highly innovative molecular or cellular analysis technologies for basic and clinical cancer research. The emphasis of this FOA is on supporting the development of novel molecular and cellular analysis capabilities with a high degree of technical innovation with the potential to significantly affect and transform investigations exploring the molecular and cellular basis of cancer. If successful, these technologies should accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, epidemiology, and/or cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be based on molecular and/or cellular characterizations of cancer.
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Federal Grant Title: | Innovative Molecular Analysis Technologies for Cancer Research (R21) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-CA-15-002 |
Type of Funding: | Grant |
CFDA Numbers: | 93.394 |
CFDA Descriptions: | Cancer Detection and Diagnosis Research |
Current Application Deadline: | Sep 22, 2015 |
Original Application Deadline: | Sep 22, 2015 |
Posted Date: | Jan 8, 2015 |
Creation Date: | Jan 8, 2015 |
Archive Date: | Oct 23, 2015 |
Total Program Funding: | $5,000,000 |
Maximum Federal Grant Award: | $2,000,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Special district governments
Native American tribal governments (Federally recognized)
State governments
Independent school districts
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
Public and State controlled institutions of higher education
City or township governments
For profit organizations other than small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification) - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. - Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-002.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
- • Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologi...
- • Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Ca...
- • Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate C...
- • Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic...
- • Image-Guided Cancer Interventions (STTR [R41/R42])
- • An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44)
- • In Vivo Cancer Imaging Exploratory/Developmental Grants
- More Grants from the National Institutes of Health
- • Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
- • Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
- • Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Inc...
- • Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Tri...
- • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed...